Love Lifesciences raised $133,000 in the first 24 hours after launching a crowd funding effort on WeFunder.
CEO Nick Love and CTO Bradley Hopper, Love Lifesciences
“We had many friends and family asking how they can help,” CEO Nick Love told bizblip. “One of the suggestions was a fundraising round and we received an incredible amount of feedback saying they were interested in participating because they aligned with our targets and the problem we’re trying to solve.”
The startup is developing a series of safety injection devices to prevent needle-stick and dosing error, as well as an improved injection experience for those self administering medications. Love and co-founder CTO Bradley Hopper recently completed the research and development phase on a single use device and are starting to have some made so they can be used in FDA testing.
Love Lifesciences landed a $25,000 grant from the Kansas Department of Commerce’s KITE Proof of Concept program. The innovation and commercialization incentive from the state is designed to fill the funding gap between the Federal SBIR research grant and commercial seed funding.
The Kansas City company launched in October of 2020.
Links:
